Phathom Pharmaceuticals to Discuss Financial Results
Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a promising biopharmaceutical company specializing in innovative treatments for gastrointestinal disorders, is getting ready for an important announcement. The company has scheduled a live webcast to share their financial results for the second quarter of 2025. This event is set for a Thursday morning at 8:00 am EDT, which is sure to be a significant moment for stakeholders and interested parties alike.
Details of the Upcoming Webcast
The company will provide detailed insights into its latest financial outcomes along with a comprehensive business update during the webcast. For those eager to tune in, Phathom has made it easy to access the live presentation through their official website. This approach reflects their commitment to transparency and engagement with their investors and the public.
How to Access the Presentation
Interested individuals can find information about the event in the Events & Presentations section of the Phathom website, along with the option to listen in to the live discussion. After the live session, a recording of the webcast will be available for up to 90 days for anyone who wishes to revisit the insights shared.
About Phathom Pharmaceuticals
Phathom Pharmaceuticals is making strides in the field of biotechnology by developing and bringing to market pioneering treatments for gastrointestinal diseases. Their flagship product is vonoprazan, recognized as a first-in-class potassium-competitive acid blocker (PCAB). This groundbreaking medication is marketed in the U.S. under the brand name VOQUEZNA, specifically designed to alleviate heartburn associated with Non-Erosive GERD in adults.
Innovative Treatment Options
Moreover, Phathom Pharmaceuticals offers a range of treatment solutions that include VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK. These formulations also incorporate amoxicillin and clarithromycin and are used for treating H. pylori infection. This diverse portfolio not only enhances patient care but also highlights the company's commitment to advancing therapeutic options in gastrointestinal health.
Staying Connected
For ongoing updates, stakeholders are encouraged to visit Phathom's official website. Following the company on their social media platforms will also keep individuals informed about future developments and innovations as they unfold.
Contact Information
Should there be any inquiries regarding the webcast or about Phathom Pharmaceuticals in general, interested parties can easily reach out to their media or investor relations contacts. Nick Benedetto, handling media relations, and Eric Sciorilli from investor relations are both available to assist with any questions.
Frequently Asked Questions
What is Phathom Pharmaceuticals focused on?
Phathom Pharmaceuticals concentrates on developing pharmaceutical products for gastrointestinal diseases, particularly utilizing innovative treatments.
When will the webcast for the financial results take place?
The webcast is scheduled for Thursday at 8:00 am EDT, where the company will unveil its financial results.
Where can I access the webcast?
The webcast can be accessed on the Events & Presentations section of Phathom's official website.
What products does Phathom offer?
Phathom offers VOQUEZNA and its related formulations, including VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK, which are utilized for treating conditions like GERD and H. pylori infections.
Who can I contact for more information?
For further inquiries, media can contact Nick Benedetto, and investors can reach out to Eric Sciorilli at Phathom Pharmaceuticals.